Molecular Partners (MOLN) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Molecular Partners Revenue Highlights


Latest Revenue (Y)

$7.04M

Latest Revenue (Q)

$2.74M

Main Geography (Y)

SWITZERLAND

Molecular Partners Revenue by Period


Molecular Partners Revenue by Year

DateRevenueChange
2023-12-31$7.04M-96.29%
2022-12-31$189.56M1931.68%
2021-12-31$9.33M-0.15%
2020-12-31$9.34M-54.16%
2019-12-31$20.38M96.84%
2018-12-31$10.36M-48.27%
2017-12-31$20.02M-13.13%
2016-12-31$23.04M-20.88%
2015-12-31$29.12M9.37%
2014-12-31$26.63M-17.87%
2013-12-31$32.42M-

Molecular Partners generated $7.04M in revenue during NA 2023, up -96.29% compared to the previous quarter, and up 67.97% compared to the same period a year ago.

Molecular Partners Revenue by Quarter

DateRevenueChange
2024-03-31$2.74M165.31%
2023-12-31$1.03M-59.39%
2023-09-30$2.54M512.29%
2023-06-30$415.00K-86.39%
2023-03-31$3.05M13.26%
2022-12-31$2.69M15.23%
2022-09-30$2.34M-80.11%
2022-06-30$11.75M-93.20%
2022-03-31$172.78M9633.97%
2021-12-31$1.77M-49.67%
2021-09-30$3.53M9.77%
2021-06-30$3.21M294.23%
2021-03-31$815.00K-47.25%
2020-12-31$1.54M445.94%
2020-09-30$283.00K-87.89%
2020-06-30$2.34M-
2020-03-31$2.34M-54.16%
2019-12-31$5.10M-
2019-09-30$5.10M-
2019-06-30$5.10M-
2019-03-31$5.10M96.84%
2018-12-31$2.59M-
2018-09-30$2.59M-
2018-06-30$2.59M-
2018-03-31$2.59M-48.27%
2017-12-31$5.00M-
2017-09-30$5.00M-
2017-06-30$5.00M-
2017-03-31$5.00M-13.13%
2016-12-31$5.76M-
2016-09-30$5.76M-
2016-06-30$5.76M-
2016-03-31$5.76M-20.88%
2015-12-31$7.28M-
2015-09-30$7.28M-
2015-06-30$7.28M-
2015-03-31$7.28M9.37%
2014-12-31$6.66M-
2014-09-30$6.66M-
2014-06-30$6.66M-
2014-03-31$6.66M-17.87%
2013-12-31$8.10M-
2013-09-30$8.10M-
2013-06-30$8.10M-
2013-03-31$8.10M-

Molecular Partners generated $2.74M in revenue during Q1 2024, up 165.31% compared to the previous quarter, and up 101.67% compared to the same period a year ago.

Molecular Partners Revenue Breakdown


Molecular Partners Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
SWITZERLAND$7.04M$179.90M-
UNITED STATES-$9.65M$9.33M

Molecular Partners's latest annual revenue breakdown by geography, as of Dec 23: SWITZERLAND (100.00%).

Molecular Partners Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
TRDAEntrada Therapeutics$129.01M$94.69M
MOLNMolecular Partners$7.04M$2.74M
HCWBHCW Biologics$2.84M$618.85K
MNOVMediciNova$1.00M-
OPTOpthea$108.41K$61.27K
ANEBAnebulo Pharmaceuticals--
RZLTRezolute--
ANTXAN2 Therapeutics--
PHVSPharvaris--
RLYBRallybio-$299.00K
CYTCyteir Therapeutics--
ELYMEliem Therapeutics--
PMVPPMV Pharmaceuticals--
MLYSMineralys Therapeutics--
VIGLVigil Neuroscience--
GLUEMonte Rosa Therapeutics-$4.70M
EWTXEdgewise Therapeutics--
PEPGPepGen--
CSBRChampions Oncology--

MOLN Revenue FAQ


Molecular Partners's yearly revenue for 2023 was $7.04M, representing a decrease of -96.29% compared to 2022. The company's yearly revenue for 2022 was $189.56M, representing an increase of 1931.68% compared to 2021. MOLN's yearly revenue for 2021 was $9.33M, representing a decrease of -0.15% compared to 2020.

Molecular Partners's quarterly revenue for Q1 2024 was $2.74M, a 165.31% increase from the previous quarter (Q4 2023), and a -10.23% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $1.03M, a -59.39% decrease from the previous quarter (Q3 2023), and a -61.68% decrease year-over-year (Q4 2022). MOLN's quarterly revenue for Q3 2023 was $2.54M, a 512.29% increase from the previous quarter (Q2 2023), and a 8.73% increase year-over-year (Q3 2022).

Molecular Partners's revenue growth rate for the last 3 years (2021-2023) was -24.57%, and for the last 5 years (2019-2023) was -65.47%.